Sort
23,748 grants matching “melanoma”
UV damage, repair, and mutagenesis
$335,916Gerd P Pfeifer · Beckman Research Institute/City Of Hope · R37 · FY2006 · ES
NATURAL KILLER CELLS: ACQUISITION OF CD16 AND REGULATION OF NEGATIVE SIGNALING
$335,892Michael A Caligiuri · Ohio State University · P01 · FY2015 · CA
NATURAL KILLER CELLS: ACQUISITION OF CD16 AND REGULATION OF NEGATIVE SIGNALING
$335,892Michael A Caligiuri · Ohio State University · P01 · FY2016 · CA
Association of Inherited Variation in Immune Mediated Adverse Events and Respons
$335,891Katherine L Nathanson · Wistar Institute · P50 · FY2016 · CA
Ion Channel and Calcium Signaling in Ultraviolet Light Transduction in Human Skin
$335,888Elena Oancea · Brown University · R01 · FY2017 · AR
PAX3 pathways in melanoma
$335,884Deborah Lang · Boston University Medical Campus · R01 · FY2016 · CA
Induction of Therapeutic Immunity in the Tumor Microenvironment
$335,873Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · CA
Cryptic Domains of Collagen-IV in Tumor Growth
$335,687Peter C. Brooks · Mainehealth · R01 · FY2010 · CA
Cryptic Domains of Collagen-IV in Tumor Growth
$335,687Peter C. Brooks · Mainehealth · R01 · FY2008 · CA
Cryptic Domains of Collagen-IV in Tumor Growth
$335,687Peter C. Brooks · Mainehealth · R01 · FY2009 · CA
Novel Modulators of TGFÃ1 signaling in regulation of remyelination by neural stem cells
$335,675Jayshree Samanta · University Of Georgia · R01 · FY2025 · NS
Identifying and targeting evolutionary trajectories in cancer
$335,673Michael Hemann · Massachusetts Institute Of Technology · R01 · FY2023 · CA
Mechanism and Inhibition of Collagenolytic Activity
$335,644Gregg B Fields · Torrey Pines Inst For Molecular Studies · R01 · FY2013 · CA
Sr. Leadership
$335,538William L. Carroll · New York University School Of Medicine · P30 · FY2012 · CA
Transduction of T cells to improve migration to tumor
$335,525Patrick Hwu · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
Tumor Neovasculature Vector Targeting
$335,519Sidney Kimmel Cancer Center · R21 · FY2003 · CA
Cancer Pain: Nerve/Tumor Interactions
$335,452Alvin James Beitz · University Of Minnesota · R01 · FY2008 · CA
'Fat'Nucleosides and Nucleotides
$335,406University Of Maryland Balt Co Campus · R01 · FY2005 · AI
Mechanism-based targeting of unique survival signaling in residual tumors
$335,400Kris C. Wood · Duke University · R01 · FY2024 · CA
Cancer and Stroma-Targeted Immunotherapy with a Gentically Modified DC Vaccine
$335,350Xiaotong Song · Baylor College Of Medicine · R01 · FY2011 · CA
Characterization of Mutagenesis, Mutational Spectra and Mechanisms of Toxicity
$335,314Gerald N Wogan · Massachusetts Institute Of Technology · P01 · FY2013 · CA
Project 2 - PCG-1 Signaling and Mitochondrial Stress in Melanoma
$335,275Marcus W Bosenberg · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2016 · CA
Targeting antigen presentation to improve immunotherapy responses in breast cancer
$335,250Justin M Balko · Vanderbilt University Medical Center · P50 · FY2023 · CA
Targeting antigen presentation to improve immunotherapy responses in breast cancer
$335,250Justin M Balko · Vanderbilt University Medical Center · P50 · FY2019 · CA
Targeting antigen presentation to improve immunotherapy responses in breast cancer
$335,248Justin M Balko · Vanderbilt University Medical Center · P50 · FY2022 · CA